Women's Health

Although the risks are still, individuals with a history of migraines should be aware of and consult with their physicians, investigators say.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses the treatments for hypoactive sexual desire disorder currently available and those not yet approved.

In episode 7 of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, spoke with ChiChi Illonzo Momah, PharmD, RPh, about women in pharmacy ownership.

In this month's episode, we spoke with Savannah Sparks, PharmD, IBCLC, about her work both as a pharmacist and as a board certified lactation consultant.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses the origin of the historical idea that sexual dysfunction in women is primarily based in emotional and/or psychological conditions.

In the sixth episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, sat down with Jennifer Palazzolo, PharmD, RPh.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses how hypoactive sexual desire disorder in women was defined and treated historically.

Investigators used SC144, an FDA-approved molecule, to find a new pathway for a generation of nonhormonal contraceptives.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses some social and cultural aspects that may contribute to hypoactive sexual desire disorder going untreated in women.

Experts discuss women's health and health care during the COVID-19 pandemic as part of the Pharmacy Times® Pharmacy Focus webcast series.

In the fifth episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, sat down with Joanna Lewis, PharmD, MBA and Christina Madison, PharmD, FCCP, AAHIVP.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses some of the common practices for the treatment of hypoactive sexual desire disorder in women and men.

Those with the disorder during gestation and who were examined 2 to 7-years after delivery had a more than 3-fold increased risk for incident high blood pressure, results of the analysis show.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses whether hypoactive sexual desire disorder is associated with psychological and/or emotional components.

Oral ibrexafungerp, a fungicidal oral treatment to prevent recurrent vaginal yeast infections, achieved superiority over the placebo for the primary and key secondary study endpoints.

One out of every 4 pharmacists in Georgia said emergency contraception was not available at the store and ended the call.

In the fourth episode of Coffee With Suzy, we listened back to some of the best moments from the series so far.

Sexual health is directly linked to mental health, Ramsden said, and both issues often go under-investigated in women.

New study results show that rapidly adding pounds in the first and final months of gestation likely plays a key role in the development of excess fat tissue in female children and adolescents.

Selinexor demonstrated a 37% increase in probability that patients treated with the drug will be in remission at 12 months.

Trametinib emerged as a novel therapeutic approach for low-grade serous carcinoma due to a high prevalence of activating mutations in the mitogen-activated protein kinase signaling pathway.

In the third episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, spoke with Seena Haines, PharmD, BCACP, to share insights on improving self-care for women in pharmacy.

Remifemin provides an alternative to hormone replacement therapy for the treatment of menopausal symptoms.

OptiBalance is a probiotic that helps at the start of menstruation to maintain a healthy balance.